ProMIS Neurosciences Inc. is a Canadian biotechnology company focused on the discovery and development of precision medicine for neurodegenerative diseases, including Alzheimer’s and Parkinson’s. Using its proprietary antibody technology, ProMIS aims to target specific toxic proteins associated with these diseases, offering the potential for more effective treatments.
